Skip to content
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

  • Home
  • About Us
    • Cardiawave
    • Mission and values
    • The Team
    • Careers
  • Aortic Stenosis
    • Unmet Medical Need
    • Current Treatment
  • Health Professionals
    • Our device: Valvosoft® 
    • Scientific Publications
    • Congresses
  • News
    • News
    • Press releases
  • Contact
About Us

📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!

Feb 16, 2026 HeleneCardiawave 0
About Us

🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

Jan 29, 2026 HeleneCardiawave 0
About Us

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉

Jan 22, 2026 HeleneCardiawave 0
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026 HeleneCardiawave 0
Events

Cardiawave at JESFC 2026!

Jan 8, 2026 HeleneCardiawave 0
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025 HeleneCardiawave 0

Blog

About Us

Cardiawave finaliste de l’Espace Innovation du Fonds FHF !

May 7, 2024
READ MORE
Events

Cardiawave at EuroPCR 2024, on May 14-17, 2024 !  

May 2, 2024
READ MORE
About Us

Cardiawave mise en lumière par le magazine Pharmaceutiques !

Apr 30, 2024
READ MORE
Events

Cardiawave at LSX World Congress 2024, on April 29-30, 2024 !  

Apr 25, 2024
READ MORE
Press Release

Cardiawave appoints Olivier Pierron as its Chief Executive Officer

Apr 16, 2024
READ MORE
Press Release

Cardiawave annonce la nomination d’Olivier Pierron en tant que Directeur Général

Apr 16, 2024
READ MORE
Press Release

Cardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis at the 73rd Annual Conference of the ACC – April 6–8, 2024, Atlanta (GA)

Apr 5, 2024
READ MORE
Press Release

Cardiawave présentera les résultats de suivi à 30 jours de son étude pivot « Valvosoft® Pivotal Study » pour le traitement de la sténose valvulaire aortique sévère symptomatique à la 73ème Conférence annuelle de l’ACC – 6-8 avril 2024

Apr 5, 2024
READ MORE
About Us

Les fondateurs de Cardiawave lauréats du Palmarès des Inventeurs 2024 de Le Point!

Mar 7, 2024
READ MORE
About Us

Cardiawave mise en lumière par Notre Temps!

Mar 5, 2024
READ MORE

Posts pagination

PrevPrevious page Page 1 … Page 7 Page 8 Page 9 … Page 22 NextNext page

Categories

  • About Us
  • Aortic Stenosis
  • Careers
  • Clinical Studies
  • Corporate News
  • Events
  • Other news
  • Press Release
  • Scientific Publications

Featured Posts

About Us

📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!

Feb 16, 2026 HeleneCardiawave 0
About Us

🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

Jan 29, 2026 HeleneCardiawave 0
About Us

Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉

Jan 22, 2026 HeleneCardiawave 0
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026 HeleneCardiawave 0
Events

Cardiawave at JESFC 2026!

Jan 8, 2026 HeleneCardiawave 0
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025 HeleneCardiawave 0

l Latest news

  • 📢 Cardiawave welcomes Hardip Thakerar to its Board of Directors!
  • 🎉 Cardiawave has just reached 8,000 followers on LinkedIn!

l Our social networks

  • LinkedIn
  • Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l February 5th 2026
  • Legal Mentions